Abstract
The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.
Original language | English (US) |
---|---|
Pages (from-to) | 801-805 |
Number of pages | 5 |
Journal | Cell Stem Cell |
Volume | 22 |
Issue number | 6 |
DOIs |
|
State | Published - Jun 1 2018 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology